Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1259968.RA9Fe9rhW40qZPWeVGfAo1P0qAKXBhA-8y7mkwGB3aGhs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1259968.RA9Fe9rhW40qZPWeVGfAo1P0qAKXBhA-8y7mkwGB3aGhs130_assertion type Assertion NP1259968.RA9Fe9rhW40qZPWeVGfAo1P0qAKXBhA-8y7mkwGB3aGhs130_head.
- NP1259968.RA9Fe9rhW40qZPWeVGfAo1P0qAKXBhA-8y7mkwGB3aGhs130_assertion description "[Survival rates of high-risk neuroblastoma remain less than 50%, with amplification of the MYCN oncogene the most important aberration associated with poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259968.RA9Fe9rhW40qZPWeVGfAo1P0qAKXBhA-8y7mkwGB3aGhs130_provenance.
- NP1259968.RA9Fe9rhW40qZPWeVGfAo1P0qAKXBhA-8y7mkwGB3aGhs130_assertion evidence source_evidence_literature NP1259968.RA9Fe9rhW40qZPWeVGfAo1P0qAKXBhA-8y7mkwGB3aGhs130_provenance.
- NP1259968.RA9Fe9rhW40qZPWeVGfAo1P0qAKXBhA-8y7mkwGB3aGhs130_assertion SIO_000772 25640269 NP1259968.RA9Fe9rhW40qZPWeVGfAo1P0qAKXBhA-8y7mkwGB3aGhs130_provenance.
- NP1259968.RA9Fe9rhW40qZPWeVGfAo1P0qAKXBhA-8y7mkwGB3aGhs130_assertion wasDerivedFrom befree-2016 NP1259968.RA9Fe9rhW40qZPWeVGfAo1P0qAKXBhA-8y7mkwGB3aGhs130_provenance.
- NP1259968.RA9Fe9rhW40qZPWeVGfAo1P0qAKXBhA-8y7mkwGB3aGhs130_assertion wasGeneratedBy ECO_0000203 NP1259968.RA9Fe9rhW40qZPWeVGfAo1P0qAKXBhA-8y7mkwGB3aGhs130_provenance.